GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

No trades
See on Supercharts

GSKD bonds

Below is the list of GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol
YTM %
Volume
Price %
Coupon %
Maturity date
Outstanding amt
Face value
Min denom amt
Issuer
883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-20425.76%094.53%5.25%2042-04-10477.82 M GBP1,000.00 GBP50,000.00 GBPGlaxoSmithKline Capital Plc
117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-20455.61%8.46 K82.51%4.25%2045-12-18370.79 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-20395.56%0107.50%6.38%2039-03-09631.3 M GBP1,000.00 GBP50,000.00 GBPGlaxoSmithKline Capital Plc
XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035
5.24%073.09%1.63%2035-05-12750 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
5.12%7.79 M89.39%4.20%2043-03-18500 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
4.87%1.3 M113.97%6.38%2038-05-152.75 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-20334.75%0103.35%5.25%2033-12-19574.17 M GBP1,000.00 GBP1,000.00 GBPGlaxoSmithKline Capital Plc
772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-20344.66%0105.28%5.38%2034-04-15500 M USD1,000.00 USD1,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
4.57%1.1 M102.27%4.88%2035-04-15750 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028
4.14%091.84%1.25%2028-10-12750 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
4.13%5 K101.51%4.50%2030-04-15850 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029
4.05%097.68%3.38%2029-06-011 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028
3.98%099.71%3.88%2028-05-151.75 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
3.75%200 K100.81%4.32%2027-03-12400 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
XXS293369275GSK Capital BV 3.25% 19-NOV-2036
3.55%097.25%3.25%2036-11-19600 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS255381776GSK Capital BV 3.125% 28-NOV-2032
3.21%099.40%3.13%2032-11-28700 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS293369143GSK Capital BV 2.875% 19-NOV-2031
3.06%098.97%2.88%2031-11-19700 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030
2.89%095.08%1.75%2030-05-21750 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029
2.69%095.07%1.38%2029-09-12500 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
XXS255381768GSK Capital BV 3.0% 28-NOV-2027
2.47%0101.09%3.00%2027-11-28500 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026
2.22%098.81%1.00%2026-09-12700 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026
2.14%099.41%1.25%2026-05-211 B EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-20270.87%0112.19%3.38%2027-12-20307.77 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-20280.88%2028-09-2142.5 B JPY100,000,000.00 JPY100,000,000.00 JPYGlaxoSmithKline Capital Plc
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027
131 K100.37%4.91%2027-03-12600 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc